tradingkey.logo
tradingkey.logo
Pesquisar

Insulet Corp

PODD
Adicionar à lista de desejos
156.270USD
-1.470-0.93%
Horário de mercado ETCotações atrasadas em 15 min
10.82BValor de mercado
36.25P/L TTM

Mais detalhes de Insulet Corp Empresa

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Informações de Insulet Corp

Código da empresaPODD
Nome da EmpresaInsulet Corp
Data de listagemMay 15, 2007
CEOMcevoy (Ashley)
Número de funcionários3900
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 15
Endereço100 Nagog Park
CidadeACTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01720-3440
Telefone19786007000
Sitehttps://www.omnipod.com
Código da empresaPODD
Data de listagemMay 15, 2007
CEOMcevoy (Ashley)

Executivos da empresa Insulet Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
29.36K
+5.65%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
19.92K
+8.33%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
16.55K
-4.75%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
10.35K
+33.33%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
8.67K
+32.17%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
6.75K
+22.59%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
5.36K
+35.90%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
3.55K
-11.77%
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
3.11K
-123.87%
Dr. Wayne A.I. Frederick, M.D.
Dr. Wayne A.I. Frederick, M.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
29.36K
+5.65%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
19.92K
+8.33%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
16.55K
-4.75%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
10.35K
+33.33%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
8.67K
+32.17%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
6.75K
+22.59%

Perguntas frequentes

Quem são os cinco principais acionistas de Insulet Corp?

Os cinco principais acionistas de Insulet Corp são: Dr. Jessica Hopfield, Ph.D.

Quantas instituições possuem ações da Insulet Corp (PODD)?

Em 2026Q1, 1624 instituições possuíam ações da Insulet Corp, com valor de mercado aproximado de 73.18M, representando 105.65% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1617450.00.

Qual é a maior fonte de receita da Insulet Corp?

Em 2026Q1, o segmento de negócios U.S.Omnipod gerou a maior receita para Insulet Corp, totalizando 1.92B e representando 70.89% da receita total.
KeyAI